Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1983 • 52,849 citations

Immunity to Methylcholanthrene-Induced Sarcomas

1957 • 1,241 citations

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.

1981 • 516 citations

Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo.

1981 • 395 citations

Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice

1976 • 198 citations

Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.

1981 • 184 citations

Suppressor Cells: Permitters and Promoters of Malignancy?

1979 • 162 citations

Augmentation of the human immune response by cyclophosphamide.

1982 • 136 citations

Immunological Enhancement: A Study of Blocking Antibodies

1972 • 120 citations

In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration.

1982 • 104 citations

Macrophage-Mediated Suppression of Natural Killer Cell Activity in Mice Bearing Lewis Lung Carcinoma2

1986 • 70 citations

Experimentelle Beiträge zum Dosis-Problem in der Krebs-Chemotherapie und zur Wirkungsweise von Endoxan^*

1963 • 64 citations

Induction of autoreactive T lymphocytes and their suppressor cells by cyclophosphamide

1978 • 59 citations

Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.

1984 • 53 citations

Leukämie L 5222 des Rattenstammes BD IX. Eine durch Äthylnitrosoharnstoff induzierte monozytärmyeloische, transplantierbare Form für zytochemische und chemotherapeutische Studien

1974 • 36 citations

Differences in the effects of host suppression on the adoptive immunotherapy of subcutaneous and visceral tumors.

1986 • 33 citations

Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

1984 • 30 citations

Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation.

1979 • 26 citations

Differential Induction of Suppressor Macrophages by Cloned Lewis Lung Carcinoma Variants in Mice<xref ref-type="fn" rid="FN2">2</xref>

1986 • 26 citations

The effect of cyclophosphamide in vivo on the expression of lymphocyte markers, detected by monoclonal antibodies, in the rat

1986 • 21 citations

In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets

1987 • 17 citations

Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers

1986 • 16 citations

Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

1985 • 15 citations

Adjuvant chemoimmunotherapy of cancer: influence of tumor burden and role of functional immune effector cells in mice.

1986 • 7 citations

Oxazaphosphorine effects in L 5222 rat leukemia.

1987 • 7 citations

Grundlagen der Therapie mit Herzglykosiden

1963 • 5 citations

Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.

1987 • 5 citations

Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor

1985 • 4 citations